CAS 2094516-02-4

Cinpanemab

CAS : 2094516-02-4

Cinpanemab (BIIB054) is a novel human monoclonal antibody with affinity for alpha-synuclein residues 1-10.

Degré de pureté : > 95%

Couleur et forme : Liquid

Masse moléculaire : 150 kDa

Ref: TM-T76861

Cinpanemab

CAS : 2094516-02-4

Cinpanemab

Degré de pureté : ≥95%

Ref: 54-BUP20293

Cinpanemab

CAS : 2094516-02-4

A human-derived monoclonal antibody binding preferentially to aggregated forms of extracellular α-synuclein for the treatment of early Parkinson's disease.

Ref: 3D-CLA1575